Article

  • The EMBO Journal (2001) 20, 4122 - 4131
  • doi:10.1093/emboj/20.15.4122

Protein phosphatase 2A and its B56 regulatory subunit inhibit Wnt signaling in Xenopus

Xinghai Li1, H.Joseph Yost1, David M. Virshup1,2 and Joni M. Seeling1

  1. Department of Oncological Sciences and the Center for Children, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA
  2. Division of Hematology/Oncology, Department of Pediatrics, University of Utah, Salt Lake City, UT 84112, USA

Correspondence to:

Joni M. Seeling, E-mail: jseeling@hci.utah.edu

Received 19 April 2001; Accepted 8 June 2001; Revised 8 June 2001


Wnt signaling increases beta-catenin abundance and transcription of Wnt-responsive genes. Our previous work suggested that the B56 regulatory subunit of protein phosphatase 2A (PP2A) inhibits Wnt signaling. Okadaic acid (a phosphatase inhibitor) increases, while B56 expression reduces, beta-catenin abundance; B56 also reduces transcription of Wnt-responsive genes. Okadaic acid is a tumor promoter, and the structural A subunit of PP2A is mutated in multiple cancers. Taken together, the evidence suggests that PP2A is a tumor suppressor. However, other studies suggest that PP2A activates Wnt signaling. We now show that the B56, A and catalytic C subunits of PP2A each have ventralizing activity in Xenopus embryos. B56 was epistatically positioned downstream of GSK3beta and axin but upstream of beta-catenin, and axin co-immunoprecipitated B56, A and C subunits, suggesting that PP2A:B56 is in the beta-catenin degradation complex. PP2A appears to be essential for beta-catenin degradation, since beta-catenin degradation was reconstituted in phosphatase-depleted Xenopus egg extracts by PP2A, but not PP1. These results support the hypothesis that PP2A:B56 directly inhibits Wnt signaling and plays a role in development and carcinogenesis.

  • Keywords:

    • B56,
    • dephosphorylation,
    • PP2A,
    • Wnt,
    • Xenopus